155 related articles for article (PubMed ID: 33508798)
1. A Different View on the Etiopathogenesis of Attention-deficit Hyperactivity Disorder from an Inflammation Perspective.
Dursun S; Demirci E; Kilic E; Ozmen S
Clin Psychopharmacol Neurosci; 2021 Feb; 19(1):145-154. PubMed ID: 33508798
[TBL] [Abstract][Full Text] [Related]
2. Serum Levels of Interleukin-6 and Tumor Necrosis Factor Alpha in Children With Attention-Deficit Hyperactivity Disorder.
Elsadek AE; Al-Shokary AH; Abdelghani WE; Kamal NM; Ibrahim AO; El-Shorbagy HH; Suliman HA; Barseem NF; Abdel Maksoud YH; Azab SM; Nour El Din DM
J Pediatr Neurosci; 2020; 15(4):402-408. PubMed ID: 33936305
[TBL] [Abstract][Full Text] [Related]
3. Oxidative and Inflammatory Parameters in Children and Adolescents With ADHD.
Koç S; Güler EM; Derin S; Gültekin F; Aktaş S
J Atten Disord; 2023 Jun; 27(8):880-886. PubMed ID: 36879528
[TBL] [Abstract][Full Text] [Related]
4. IL-6 and TNF-α in unmedicated adults with ADHD: Relationship to cortisol awakening response.
Corominas-Roso M; Armario A; Palomar G; Corrales M; Carrasco J; Richarte V; Ferrer R; Casas M; Ramos-Quiroga JA
Psychoneuroendocrinology; 2017 May; 79():67-73. PubMed ID: 28262601
[TBL] [Abstract][Full Text] [Related]
5. Increased uncoupling protein 1 levels are associated with attention deficit and hyperactivity disorder in medication-free children.
Esad Tezcan M; Uçar HN; Vatansev H
J Psychiatr Res; 2022 Dec; 156():437-443. PubMed ID: 36327766
[TBL] [Abstract][Full Text] [Related]
6. Serum Interleukin-6 Level in Children With Attention-Deficit Hyperactivity Disorder (ADHD).
Darwish AH; Elgohary TM; Nosair NA
J Child Neurol; 2019 Feb; 34(2):61-67. PubMed ID: 30430896
[TBL] [Abstract][Full Text] [Related]
7. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.
Genc H; Dogru T; Kara M; Tapan S; Ercin CN; Acikel C; Karslioglu Y; Bagci S
Ann Hepatol; 2013; 12(4):548-55. PubMed ID: 23813132
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota and plasma cytokine levels in patients with attention-deficit/hyperactivity disorder.
Wang LJ; Li SC; Li SW; Kuo HC; Lee SY; Huang LH; Chin CY; Yang CY
Transl Psychiatry; 2022 Feb; 12(1):76. PubMed ID: 35197458
[TBL] [Abstract][Full Text] [Related]
9. Serum Visfatin, Adiponectin, and Tumor Necrosis Factor Alpha (TNF-α) Levels in Patients with Psoriasis and their Correlation with Disease Severity.
Sereflican B; Goksugur N; Bugdayci G; Polat M; Haydar Parlak A
Acta Dermatovenerol Croat; 2016 Apr; 24(1):13-9. PubMed ID: 27149125
[TBL] [Abstract][Full Text] [Related]
10. Handgrip strength, tumor necrosis factor-α, interlukin-6, and visfatin levels in oldest elderly patients with cognitive impairment.
Huang HH; Chang JC; Liu HC; Yang ZY; Yang YJ; Chen LK; Yen DH
Exp Gerontol; 2020 Dec; 142():111138. PubMed ID: 33122129
[TBL] [Abstract][Full Text] [Related]
11. Iron Deficiency Parameters in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Percinel I; Yazici KU; Ustundag B
Child Psychiatry Hum Dev; 2016 Apr; 47(2):259-69. PubMed ID: 26092605
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and immune aberrancies in attention-deficit/hyperactivity disorder (ADHD): a case-control comparison.
Verlaet AAJ; Breynaert A; Ceulemans B; De Bruyne T; Fransen E; Pieters L; Savelkoul HFJ; Hermans N
Eur Child Adolesc Psychiatry; 2019 May; 28(5):719-729. PubMed ID: 30350094
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood inflammatory markers in patients with attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis.
Misiak B; Wójta-Kempa M; Samochowiec J; Schiweck C; Aichholzer M; Reif A; Samochowiec A; Stańczykiewicz B
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Aug; 118():110581. PubMed ID: 35660454
[TBL] [Abstract][Full Text] [Related]
14. An exploration of the associations of pregnancy and perinatal features with cytokines and tryptophan/kynurenine metabolism in children with attention-deficit hyperactivity disorder (ADHD).
Oades RD
Atten Defic Hyperact Disord; 2011 Dec; 3(4):301-18. PubMed ID: 21785943
[TBL] [Abstract][Full Text] [Related]
15. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
Bilgiç A; Toker A; Işık Ü; Kılınç İ
Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
[TBL] [Abstract][Full Text] [Related]
16. Decreased serum orexin A levels in drug-naive children with attention deficit and hyperactivity disorder.
Baykal S; Albayrak Y; Durankuş F; Güzel S; Abbak Ö; Potas N; Beyazyüz M; Karabekiroğlu K; Donma MM
Neurol Sci; 2019 Mar; 40(3):593-602. PubMed ID: 30617449
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory study of pro-inflammatory and antiinflammatory cytokines in women with multiple sclerosis.
Trenova AG; Manova MG; Kostadinova II; Murdjeva MA; Hristova DR; Vasileva TV; Zahariev ZI
Folia Med (Plovdiv); 2011; 53(2):29-35. PubMed ID: 21797104
[TBL] [Abstract][Full Text] [Related]
18. Visfatin regulates the production of lipopolysaccharide-induced inflammatory cytokines through p38 signaling in murine macrophages.
Wu XT; Yang Z; Ansari AR; Xiao K; Pang XX; Luo Y; Song H
Microb Pathog; 2018 Apr; 117():55-59. PubMed ID: 29412160
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).
Sahin N; Altun H; Kurutaş EB; Fındıklı E
Bosn J Basic Med Sci; 2018 May; 18(2):126-131. PubMed ID: 29659348
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the natural killer cell, IFN- and IL-10 blood levels in children with attention-deficit/hyperactivity disorder.
El Sehmawy AA; Abd Elaziz SY; Diab FEA; Al Anany MG; Elamir RY; Ibrahim HF; Seliem N; Agiba NF
Egypt J Immunol; 2023 Jul; 30(3):13-22. PubMed ID: 37439453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
